Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Vella

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Hormones (Athens, Greece)|June 6, 2020
Onset of Marine-Lenhart syndrome and Graves' ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosisRosario Le Moli, Marco Russo, Pasqualino Malandrino, et al.
Frontiers in Endocrinology|March 10, 2017
PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF AxisVeronica Vella, Maria Luisa Nicolosi, Stefania Giuliano, et al.
Cells|September 5, 2019
Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin StimulationVeronica Vella, Maria Luisa Nicolosi, Marika Giuliano, et al.
Expert Opinion on Therapeutic Targets|June 28, 2022
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progressErnestina Marianna De Francesco, Francesca Cirillo, Veronica Vella, et al.
Molecular Cancer Research : MCR|February 1, 2008
TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradationRoberta Malaguarnera, Veronica Vella, Giuseppe Pandini, et al.
Cancer Research|October 3, 2003
p73 tumor-suppressor activity is impaired in human thyroid cancerFrancesco Frasca, Veronica Vella, Alessandra Aloisi, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2002
A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancerVeronica Vella, Giuseppe Pandini, Laura Sciacca, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2004
Interleukin-4 stimulates papillary thyroid cancer cell survival: implications in patients with thyroid cancer and concomitant Graves' diseaseVeronica Vella, Rossana Mineo, Francesco Frasca, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 19, 2025
Expanding the Clinical Profile of Mild Autonomous Cortisol Secretion: New Diagnostic Markers and Emerging ComplicationsAntonio Prinzi, Ausilia Maria Lombardo, Salvatore Finocchiaro, et al.
Cell Adhesion & Migration|March 1, 2018
A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancerAntonino Belfiore, Roberta Malaguarnera, Maria Luisa Nicolosi, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Hormones (Athens, Greece)|June 6, 2020
Onset of Marine-Lenhart syndrome and Graves' ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosisRosario Le Moli, Marco Russo, Pasqualino Malandrino, et al.
Frontiers in Endocrinology|March 10, 2017
PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF AxisVeronica Vella, Maria Luisa Nicolosi, Stefania Giuliano, et al.
Cells|September 5, 2019
Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin StimulationVeronica Vella, Maria Luisa Nicolosi, Marika Giuliano, et al.
Expert Opinion on Therapeutic Targets|June 28, 2022
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progressErnestina Marianna De Francesco, Francesca Cirillo, Veronica Vella, et al.
Molecular Cancer Research : MCR|February 1, 2008
TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradationRoberta Malaguarnera, Veronica Vella, Giuseppe Pandini, et al.
Cancer Research|October 3, 2003
p73 tumor-suppressor activity is impaired in human thyroid cancerFrancesco Frasca, Veronica Vella, Alessandra Aloisi, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2002
A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancerVeronica Vella, Giuseppe Pandini, Laura Sciacca, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2004
Interleukin-4 stimulates papillary thyroid cancer cell survival: implications in patients with thyroid cancer and concomitant Graves' diseaseVeronica Vella, Rossana Mineo, Francesco Frasca, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 19, 2025
Expanding the Clinical Profile of Mild Autonomous Cortisol Secretion: New Diagnostic Markers and Emerging ComplicationsAntonio Prinzi, Ausilia Maria Lombardo, Salvatore Finocchiaro, et al.
Cell Adhesion & Migration|March 1, 2018
A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancerAntonino Belfiore, Roberta Malaguarnera, Maria Luisa Nicolosi, et al.
Pageof 6